GO:0014909 smooth muscle cell migration: Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0014909 (smooth muscle cell migration) describes the orderly movement of a smooth muscle cell from one site to another, often during development of a multicellular organism.
• Vascular and airway smooth muscle cell migration is a hallmark of phenotypic switching in atherosclerosis, restenosis, asthma and pulmonary hypertension.
• Actin cytoskeleton remodeling, intermediate filaments and microtubules provide the mechanical machinery that drives smooth muscle cell migration.
• Mitochondrial dynamics and mitophagy are emerging regulators of vascular smooth muscle cell proliferation and migration in atherosclerosis.
• TSPAN4 controls vascular smooth muscle cell phenotypic switching and intimal hyperplasia by targeting TPM1-regulated cytoskeletal organization.
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to test causality of candidate genes in smooth muscle cell migration.
Description
GO:0014909, smooth muscle cell migration, is a biological process defined as the orderly movement of a smooth muscle cell from one site to another, often during the development of a multicellular organism. Smooth muscle cells (SMCs) are not terminally static; in response to injury, inflammation or growth factors they can switch from a contractile to a synthetic, migratory phenotype. This phenotypic plasticity is central to vascular remodeling and airway remodeling, and it is a major research focus because dysregulated SMC migration contributes to atherosclerosis, restenosis, asthma and pulmonary hypertension. Understanding the molecular control of SMC migration therefore has direct translational relevance for cardiovascular and respiratory disease.
smooth muscle cell migration At A Glance
| GO ID | GO:0014909 |
|---|---|
| GO term | smooth muscle cell migration |
| Ontology | biological_process |
| Synonym | none |
| Major function | Orderly movement of a smooth muscle cell from one site to another, often during development of a multicellular organism |
| Related cell type | Smooth muscle cells (vascular, airway, visceral) |
| Disease relevance | Atherosclerosis, restenosis, asthma, pulmonary hypertension, intimal hyperplasia |
| Key machinery | Actin cytoskeleton, intermediate filaments, microtubules, focal adhesions |
| Research methods | Live-cell imaging, scratch wound assays, CRISPR KO/KI, RNA-seq, proteomics |
What Is GO:0014909?
In our own words, GO:0014909 describes the directed, orderly movement of a smooth muscle cell from one location to another within a multicellular organism. It is a biological process that encompasses the coordinated rearrangement of the cytoskeleton, cell-matrix adhesion turnover and leading-edge protrusion that together allow a smooth muscle cell to translocate. The term is used in gene ontology annotation to capture the migration behavior of smooth muscle cells during development, tissue repair and disease-associated remodeling.
Why Is smooth muscle cell migration Important in Cell Biology?
Smooth muscle cell migration is important because it is a reversible, druggable node in the progression of major human diseases. In blood vessels, migration of vascular smooth muscle cells from the media to the intima drives neointima formation, restenosis after angioplasty and atherosclerotic plaque instability. In the airway, migration of airway smooth muscle cells contributes to the increased smooth muscle mass seen in asthma. In the pulmonary circulation, SMC migration participates in the vascular remodeling of pulmonary hypertension. Because migration is tightly coupled to phenotypic switching, mitochondrial dynamics and cytoskeletal organization, it offers multiple entry points for mechanism-based therapy.
• Drives neointima formation and restenosis after vascular injury.
• Contributes to atherosclerotic plaque progression and instability.
• Underlies airway smooth muscle remodeling in asthma.
• Participates in pulmonary vascular remodeling in pulmonary hypertension.
• Is coupled to smooth muscle cell phenotypic switching and intimal hyperplasia.
• Depends on actin cytoskeleton, intermediate filament and microtubule dynamics.
• Is regulated by mitochondrial dynamics and mitophagy.
• Can be modulated by Wnt-independent FRZB pathways.
• Provides a target for anti-remodeling therapies in cardiovascular and respiratory disease.
• Requires robust CRISPR models to distinguish causal genes from correlative markers.
What Happens During smooth muscle cell migration?
Phenotypic switching from contractile to synthetic state
In simple terms: The smooth muscle cell first changes its job from squeezing to moving.
Smooth muscle cells in mature tissues are normally contractile and quiescent. In response to injury or growth factors, they undergo phenotypic switching toward a synthetic, migratory state characterized by reduced contractile markers and increased matrix production and motility. This switch is a prerequisite for subsequent migration and is a central event in vascular remodeling and intimal hyperplasia.
Leading-edge protrusion and actin polymerization
In simple terms: The front of the cell pushes forward by building new actin filaments.
Migration begins with polarized protrusion at the leading edge, driven by actin polymerization and reorganization. The actin cytoskeleton, together with intermediate filaments and microtubules, provides the force and structural support for smooth muscle cell movement. Regulators of actin dynamics, including TPM1-associated pathways, are critical for this step.
Adhesion turnover and cell-matrix interaction
In simple terms: The cell grips the matrix at the front and lets go at the back to move forward.
Efficient migration requires coordinated formation of new adhesions at the leading edge and disassembly of old adhesions at the rear. This turnover allows the cell to transmit traction forces to the extracellular matrix and to translocate. Cytoskeletal and adhesion remodeling are therefore inseparable from the migration process in smooth muscle cells.
Mitochondrial dynamics and metabolic support
In simple terms: The cell's power plants reshape themselves to supply energy for movement.
Mitochondrial dynamics and mitophagy have been identified as regulators of vascular smooth muscle cell proliferation and migration in atherosclerosis. Mitochondrial fission, fusion and clearance influence the metabolic and redox state of the cell, which in turn affects its ability to sustain migration. This links metabolic control to the mechanical program of migration.
Extracellular and receptor-mediated regulation
In simple terms: Signals from outside the cell tell it where and when to move.
Growth factors, cytokines and matrix-derived signals regulate smooth muscle cell migration through receptor-mediated pathways. Emerging regulators of vascular smooth muscle cell migration include a broad set of signaling and cytoskeletal proteins. Wnt-independent FRZB pathways can modulate vascular smooth muscle cell phenotype, showing that non-canonical cues also contribute to migratory behavior.
Key Genes Involved in GO:0014909 smooth muscle cell migration
The following genes and proteins have been experimentally implicated in smooth muscle cell migration and its regulation, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TPM1 | Regulates actin cytoskeletal organization | Target of TSPAN4 in intimal hyperplasia |
| TSPAN4 | Controls phenotypic switching and intimal hyperplasia | Regulates TPM1-dependent cytoskeletal organization |
| FRZB | Modulates vascular smooth muscle cell phenotype | Wnt-independent pathway in SMC phenotype |
| ACTA2 | Smooth muscle contractile marker | Phenotypic switching readout |
| MYH11 | Smooth muscle myosin heavy chain | Contractile-to-synthetic switch marker |
| CNN1 | Calponin, contractile apparatus | Marker of differentiated SMC |
| MYOCD | Master regulator of SMC differentiation | Controls contractile gene program |
| SRF | Serum response factor, SMC gene transcription | Regulates SMC differentiation and migration |
| ELN | Elastin, extracellular matrix component | Matrix remodeling in vascular disease |
| COL1A1 | Collagen type I, matrix production | Synthetic SMC phenotype marker |
| MMP2 | Matrix metalloproteinase, matrix degradation | Facilitates SMC migration through matrix |
| MMP9 | Matrix metalloproteinase, matrix degradation | Associated with SMC migration in remodeling |
| RAC1 | Rho GTPase, actin cytoskeleton regulation | Controls leading-edge protrusion |
| RHOA | Rho GTPase, contractility and adhesion | Regulates SMC migration machinery |
| CDC42 | Rho GTPase, filopodia formation | Polarized migration control |
| PTK2 | Focal adhesion kinase, adhesion turnover | Integrates matrix signals during migration |
| VCL | Vinculin, focal adhesion protein | Structural adhesion component |
How Is smooth muscle cell migration Regulated?
Smooth muscle cell migration is regulated at multiple levels. Phenotypic switching is controlled by transcription factors such as MYOCD and SRF, which maintain the contractile program and whose downregulation permits the synthetic, migratory state. Cytoskeletal regulators, including Rho GTPases and actin-binding proteins, control the mechanical steps of protrusion and adhesion turnover. Mitochondrial dynamics and mitophagy modulate the metabolic and redox environment that supports migration. In addition, non-canonical pathways such as Wnt-independent FRZB signaling can shift vascular smooth muscle cell phenotype. Together, these layers provide multiple points of experimental intervention.
smooth muscle cell migration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TSPAN4 | Intimal hyperplasia, SMC phenotypic switching | Knockout and overexpression in vascular SMC lines |
| TPM1 | Cytoskeletal organization in intimal hyperplasia | Point mutation and knock-in of TPM1 variants |
| FRZB | Vascular SMC phenotype modulation | Overexpression and knockout in SMC models |
| MMP2 | Atherosclerosis, matrix remodeling | Knockout in SMC migration assays |
| MMP9 | Vascular remodeling, restenosis | Knockout and pharmacological inhibition |
Atherosclerosis and restenosis
Vascular smooth muscle cell migration from the media to the intima is a key event in atherogenesis and in restenosis after angioplasty or stenting. Migratory SMCs contribute to neointima formation and plaque remodeling, and mitochondrial dynamics and mitophagy have been implicated in this process. TSPAN4-dependent control of TPM1-regulated cytoskeletal organization further links SMC phenotypic switching to intimal hyperplasia.
Asthma and airway remodeling
Airway smooth muscle cell migration contributes to the increased smooth muscle mass observed in asthma. Regulation of human airway smooth muscle cell migration is therefore directly relevant to asthma pathobiology and to the development of anti-remodeling strategies.
Pulmonary hypertension
Smooth muscle cell hypertrophy, proliferation, migration and apoptosis are all involved in the vascular remodeling of pulmonary hypertension. Migration of pulmonary arterial smooth muscle cells contributes to the neointimal and medial changes that raise pulmonary vascular resistance.
Intimal hyperplasia and vascular injury
After vascular injury, smooth muscle cells switch phenotype and migrate into the intima, where they contribute to intimal hyperplasia. Emerging regulators of vascular smooth muscle cell migration are being studied as potential targets to limit this maladaptive response.
From smooth muscle cell migration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is TSPAN4 required for SMC migration? | TSPAN4 knockout in vascular SMC lines |
| Does a TPM1 point mutation alter cytoskeletal organization? | TPM1 point-mutation knock-in |
| Can FRZB overexpression suppress migratory phenotype? | FRZB overexpression in SMC |
| Does mitophagy regulate SMC migration? | Knockout of mitophagy genes in SMC |
| Which Rho GTPase drives leading-edge protrusion? | RAC1 or CDC42 knockout and live imaging |
| Is a candidate gene causal in intimal hyperplasia? | SMC-specific knockout in injury models |
How to Study the smooth muscle cell migration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Scratch wound assay | Collective cell migration | SMC migration after gene perturbation |
| Boyden chamber | Directional cell migration | Chemotaxis and inhibitor testing |
| Live-cell imaging | Speed, directionality, protrusion dynamics | Cytoskeletal and mitochondrial studies |
| RNA-seq | Transcriptomic phenotype | Contractile-to-synthetic switch |
| Proteomics | Protein abundance and modifications | Cytoskeletal remodeling |
| CRISPR knockout | Loss-of-function causality | Candidate gene validation |
| CRISPR knock-in | Point mutation or tag effects | Variant function studies |
| Overexpression | Gain-of-function effects | Pathway activation studies |
Live-cell imaging and migration assays
Time-lapse microscopy, scratch wound assays and Boyden chamber assays are standard methods to quantify smooth muscle cell migration. These approaches measure speed, directionality and persistence, and can be combined with fluorescent reporters for actin, focal adhesions or mitochondria.
Transcriptomic and phenotypic profiling
RNA-seq and quantitative PCR are used to monitor the contractile-to-synthetic switch by measuring markers such as ACTA2, MYH11 and CNN1 alongside synthetic markers. This helps link migration to phenotypic state.
Proteomics and cytoskeletal analysis
Mass spectrometry-based proteomics and biochemical fractionation can identify changes in cytoskeletal and adhesion proteins during migration. Such analyses complement imaging by revealing pathway-level changes in actin, intermediate filament and microtubule networks.
Genetic perturbation with CRISPR
CRISPR knockout, point mutation, knock-in and overexpression are used to test causality of candidate genes in smooth muscle cell migration. These tools allow precise dissection of pathways such as TSPAN4-TPM1 and FRZB signaling in SMC phenotype.
How CRISPR Can Be Used to Study GO:0014909 smooth muscle cell migration
Knockout
CRISPR knockout is used to delete candidate genes and test whether they are required for smooth muscle cell migration. For example, knockout of TSPAN4 or its downstream effectors can reveal loss of migratory capacity and altered cytoskeletal organization. Knockout of mitophagy-related genes can test the role of mitochondrial dynamics in migration.
Point Mutation
Point-mutation knock-in allows precise testing of amino acid changes in genes such as TPM1 that may alter actin binding or cytoskeletal regulation. This approach distinguishes pathogenic variants from benign polymorphisms in smooth muscle cell migration research.
Knock-in
Knock-in of reporters or tags, such as fluorescently labeled cytoskeletal proteins, enables live tracking of migration machinery. Knock-in of disease-associated alleles can model how specific variants affect SMC phenotype and motility.
Overexpression
Overexpression of candidate genes, such as FRZB, can test gain-of-function effects on smooth muscle cell phenotype and migration. This is useful for pathways where increased signaling is hypothesized to suppress or promote migration.
How EDITGENE Supports smooth muscle cell migration Research
Researchers studying smooth muscle cell migration-related genes often need to determine whether a candidate gene is causally involved in migration or merely correlated with phenotypic switching. Rigorous causal inference requires precise genetic models that can delete, mutate, tag or overexpress the gene of interest in relevant smooth muscle cell backgrounds.
Contact EDITGENE today to design your custom CRISPR model for smooth muscle cell migration research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| ITGB3 Knockout HEK293 Cell Line | EDJ-KQ818 | Human | 3690 | Details Get a Quote |
| PLAT Knockout HEK293 Cell Line | EDJ-KQ1465 | Human | 5327 | Details Get a Quote |
| CCN3 Knockout HEK293 Cell Line | EDJ-KQ1538 | Human | 4856 | Details Get a Quote |
| DDR1 Knockout HEK293 Cell Line | EDJ-KQ2579 | Human | 780 | Details Get a Quote |
| PLAT Knockout A-549 Cell Line | EDJ-KQ21030 | Human | 5327 | Details Get a Quote |
| PLAT Knockout HCT 116 Cell Line | EDJ-KQ21031 | Human | 5327 | Details Get a Quote |
| PLAT Knockout HeLa Cell Line | EDJ-KQ21032 | Human | 5327 | Details Get a Quote |
| ITGB3 Knockout HeLa Cell Line | EDJ-KQ18290 | Human | 3690 | Details Get a Quote |
| DDR1 Knockout HeLa Cell Line | EDJ-KQ18335 | Human | 780 | Details Get a Quote |
| CCN3 Knockout HCT 116 Cell Line | EDJ-KQ22511 | Human | 4856 | Details Get a Quote |
| CCN3 Knockout HeLa Cell Line | EDJ-KQ22512 | Human | 4856 | Details Get a Quote |
| DDR1 Knockout A-549 Cell Line | EDJ-KQ23264 | Human | 780 | Details Get a Quote |
| DDR1 Knockout HCT 116 Cell Line | EDJ-KQ23265 | Human | 780 | Details Get a Quote |
| Ddr1 Knockout CT26 Cell Line | EDJ-KZ180 | Mouse | 12305 | Details Get a Quote |
| ITGB3 Knockout A-549 Cell Line | EDJ-KQ62156 | Human | 3690 | Details Get a Quote |
Displaying Records 1 To 15 Of 17 Records
Frequently Asked Questions About smooth muscle cell migration
What is GO:0014909?
GO:0014909 is the Gene Ontology biological process term for smooth muscle cell migration, defined as the orderly movement of a smooth muscle cell from one site to another, often during development of a multicellular organism.
What is smooth muscle cell migration?
Smooth muscle cell migration is the directed movement of a smooth muscle cell, typically after phenotypic switching from a contractile to a synthetic state, and it contributes to vascular and airway remodeling.
What genes are involved in smooth muscle cell migration?
Genes implicated include TSPAN4, TPM1, FRZB, ACTA2, MYH11, CNN1, MYOCD, SRF, MMP2, MMP9, RAC1, RHOA, CDC42, PTK2 and VCL, among others.
Why is smooth muscle cell migration important in atherosclerosis?
Vascular smooth muscle cell migration from the media to the intima drives neointima formation and plaque remodeling, and mitochondrial dynamics and mitophagy are involved in this process.
How is smooth muscle cell migration studied?
Common methods include scratch wound assays, Boyden chambers, live-cell imaging, RNA-seq, proteomics and CRISPR-based genetic perturbation.
What is the role of the cytoskeleton in smooth muscle cell migration?
The actin cytoskeleton, intermediate filaments and microtubules provide the force and structural support for protrusion, adhesion turnover and translocation during migration.
Does TSPAN4 regulate smooth muscle cell migration?
TSPAN4 controls vascular smooth muscle cell phenotypic switching and intimal hyperplasia by targeting TPM1-regulated cytoskeletal organization.
Can FRZB modulate smooth muscle cell phenotype?
Yes, Wnt-independent FRZB pathways can modulate vascular smooth muscle cell phenotype, which is relevant to migratory behavior.
What diseases involve smooth muscle cell migration?
Atherosclerosis, restenosis, intimal hyperplasia, asthma and pulmonary hypertension all involve smooth muscle cell migration.
How can CRISPR help study smooth muscle cell migration?
CRISPR knockout, point mutation, knock-in and overexpression allow causal testing of candidate genes in smooth muscle cell migration and phenotypic switching.
Conclusion
GO:0014909, smooth muscle cell migration, is a biologically and clinically important process that links cytoskeletal dynamics, phenotypic switching and metabolic regulation to major cardiovascular and respiratory diseases. The verified literature highlights key regulators such as TSPAN4, TPM1 and FRZB, as well as the roles of actin, intermediate filaments, microtubules and mitochondrial dynamics. Precise CRISPR models are essential to move from correlation to causation in this field.
References
- 1. Afewerki T et al.. 2019. Emerging regulators of vascular smooth muscle cell migration.. J Muscle Res Cell Motil 40(2):185-196 PMID: 31254136
- 2. Salter B et al.. 2017. Regulation of human airway smooth muscle cell migration and relevance to asthma.. Respir Res 18(1):156 PMID: 28814293
- 3. Gerthoffer WT. 2007. Mechanisms of vascular smooth muscle cell migration.. Circ Res 100(5):607-21 PMID: 17363707
- 4. Tajsic T et al.. 2011. Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension.. Compr Physiol 1(1):295-317 PMID: 23737174
- 5. Li S et al.. 2025. TSPAN4 controls vascular smooth muscle cell phenotypic switching and intimal hyperplasia by targeting TPM1-regulated cytoskeletal organization.. Clin Sci (Lond) 139(19):1145-1161 PMID: 41004162
- 6. Huynh DTN et al.. 2021. Role of mitochondrial dynamics and mitophagy of vascular smooth muscle cell proliferation and migration in progression of atherosclerosis.. Arch Pharm Res 44(12):1051-1061 PMID: 34743301
- 7. Tang DD et al.. 2017. The roles and regulation of the actin cytoskeleton, intermediate filaments and microtubules in smooth muscle cell migration.. Respir Res 18(1):54 PMID: 28390425
- 8. Kim H et al.. 2025. Modulating vascular smooth muscle cell phenotype via Wnt-Independent FRZB pathways.. Arch Biochem Biophys 764:110290 PMID: 39778670
